Clinical trial
Effect of BMS-663068 on the Pharmacokinetics of Rosuvastatin
NCT02234882 is registered in ClinicalTrials.gov with ViiV Healthcare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of BMS-663068 on the Pharmacokinetics of Rosuvastatin
- Lead sponsor
- ViiV Healthcare
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- September 5, 2014
- Completion date
- October 31, 2014
- Enrollment
- 50 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.